AI assistant
IO Biotech, Inc. — Director's Dealing 2021
Nov 5, 2021
34883_dirs_2021-11-04_893ae6b9-42f8-438c-aa35-e7ab7424fdb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04
Reporting Person: Al-Hajj Muhammad (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (Right to Buy) | $12.64 | Common Stock (71301) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (47425) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (183171) | Direct |
Footnotes
F1: These Warrants vest 25% on the one-year anniversary of the May 27, 2021 vesting commencement date, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.
F2: Warrants expire in annual increments on the fifth anniversary of the vesting date.
F3: These Warrants vest 25% on the one-year anniversary of the October 15, 2021 vesting commencement date, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.